Pharmacokinetics of Briquilimab as a Conditioning Agent for Hematopoietic Stem Cell Transplantation in Patients with Severe Combined Immunodeficiency, Myelodysplastic Syndrome, or Acute Myeloid Leukemia.
2024
https://researcherprofiles.org/profile/526293603
38972509
Jung D, Long-Boyle JR, Pang WW, Gobburu JVS